Last reviewed · How we verify
Cannabinoids - 99% pure cannabinoids mix — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Cannabinoids - 99% pure cannabinoids mix (Cannabinoids - 99% pure cannabinoids mix) — Shaare Zedek Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cannabinoids - 99% pure cannabinoids mix TARGET | Cannabinoids - 99% pure cannabinoids mix | Shaare Zedek Medical Center | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cannabinoids - 99% pure cannabinoids mix CI watch — RSS
- Cannabinoids - 99% pure cannabinoids mix CI watch — Atom
- Cannabinoids - 99% pure cannabinoids mix CI watch — JSON
- Cannabinoids - 99% pure cannabinoids mix alone — RSS
Cite this brief
Drug Landscape (2026). Cannabinoids - 99% pure cannabinoids mix — Competitive Intelligence Brief. https://druglandscape.com/ci/cannabinoids-99-pure-cannabinoids-mix. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab